WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011020604) MULTIEPITOPE VACCINE FOR HER2/NEU-ASSOCIATED CANCERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/020604    International Application No.:    PCT/EP2010/005071
Publication Date: 24.02.2011 International Filing Date: 18.08.2010
Chapter 2 Demand Filed:    09.06.2011    
IPC:
A61K 39/00 (2006.01)
Applicants: PEVION BIOTECH AG [CH/CH]; Worblentalstrasse 32 CH-3063 Ittigen / Bern (CH) (For All Designated States Except US).
KAMMER, Andreas [CH/CH]; (CH) (For US Only).
AMACKER, Mario [CH/CH]; (CH) (For US Only).
ZURBRIGGEN, Rinaldo [CH/CH]; (CH) (For US Only)
Inventors: KAMMER, Andreas; (CH).
AMACKER, Mario; (CH).
ZURBRIGGEN, Rinaldo; (CH)
Agent: ZEMAN, Steven; Grϋnecker, Kinkeldey, Stockmair & Schwanhausser Leopoldstrasse 4 80802 Mϋnchen (DE)
Priority Data:
09010627.9 18.08.2009 EP
Title (EN) MULTIEPITOPE VACCINE FOR HER2/NEU-ASSOCIATED CANCERS
(FR) VACCIN MULTI-ÉPITOPIQUE POUR LES CANCERS ASSOCIÉS À LA HER2/NEU
Abstract: front page image
(EN)The present invention relates to fusion peptides comprising fragments of the cancer-related protein Her2/neu, methods of preparing such fusion peptides, delivery systems associated with such fusion peptides, compositions comprising such fusion peptides and/or delivery systems, and medical uses of such fusion peptides, delivery systems and/or compositions for the prevention, treatment and/or amelioration of a cancer associated with expression or over-expression of the Her2/neu protein.
(FR)La présente invention a pour objet des peptides de fusion comprenant des fragments de la protéine Her2/neu associée au cancer, des méthodes de préparation de tels peptides de fusion, des systèmes d'administration associés à de tels peptides de fusion, des compositions comprenant de tels peptides de fusion et/ou des systèmes d'administration, et des utilisations médicales de tels peptides de fusion, des systèmes d'administration et/ou des compositions pour la prévention, le traitement et/ou l'amélioration d'un cancer associé à l'expression ou à la surexpression de la protéine Her2/neu.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)